七月 2026
- Home
- Laxai
七月 2026的Laxai市场份额分析
A Global Resource ForSmall Molecule R&DDevelopmentManufacturingDiscovery Services Specialty Chemicals A Global Resource For Small Molecule R&DDevelopmentManufacturingDiscovery Services Specialty Chemicals Learn More Pioneering Excellence A leading Contract Research, Development, and Manufacturing Organization (CRDMO) committed to delivering innovative solutions that meet the unique needs and requirements of our clients in the pharmaceutical, biotechnology, and other industries. With more than 15 years of experience, we have established a reputation for excellence in custom synthesis, process development, scale-up, and manufacturing of high-quality specialty chemicals, including fine chemicals, intermediates, and APIs. Our state-of-the-art facilities, advanced technology platforms, and strict quality control systems enable us to provide reliable, cost-effective, and efficient services to our clients. Innovative Solutions Tailored For You Discovery Services We offer comprehensive Integrated Drug Discovery services to advance your programs from target identification to IND filing. Our approach accelerates your programs while ensuring efficiency and cost-effectiveness at every stage. Manufacturing We offer comprehensive manufacturing services to ensure quality, efficiency, and sustainable supplies of NCEs, APIs, KSMs, RSMs, and advanced intermediates at various phases of development and commercialization. Development We provide end-to-end development solutions that ensure successful manufacturing campaigns, supplying compounds for IND Tox batches, clinical trials, and commercial requirements. Specialty Chemicals Our expertise in handling high-energy chemistries and high-pressure reactions makes LAXAI a unique player, offering a wide range of specialty chemicals across various industries. More than 15 years of experience More than a decade of unparalleled experience in offering end-to-end Scientific Solutions 17 0% Years In Industry 250+ 0% Scientist 150+ 0% CMC Projects
Laxai(包含公司地区分支机构)
查看更多网站流量和参与度信息- laxai.com
Laxai收入截至 七月 2026为 2M - 5M
Laxai主要域名产生的收入
3 年中Laxai主要域名的收入
Laxai主要域名的收入
Laxai热门域名的总访问量
了解Laxai市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Laxai热门域名的平均访问时长
分析Laxai参与度指标。
过去 3 个月的平均访问时长
子公司明细
Laxai热门域名的平均页面浏览量
了解Laxai如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Laxai 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Laxai Life Sciences Private Limited hired DA Jeyaraj as President on Apr 7th '25.Hyderabad, India - April 7, 2025 - LAXAI, a leading Contract Research, Development, and Manufacturing Organization (CRDMO) specializing in small molecules, today announced the appointment of Dr. DA Jeyaraj as the new President of LAXAI Discovery Services (LDS).
四月 7, 2025阅读更多
新闻Laxai Life Sciences Private Limited hires Susan Billings as Board of Directors.LAXAI appoints Dr. Susan Billings to Board of Directors.
三月 27, 2025阅读更多
新闻Signet Healthcare Partners invested into Laxai Life Sciences Private Limited on Oct 24th '22.LAXAI Inc. ("LAXAI") announced today that it has received a growth capital investment from SIGNET Healthcare Partners ("SIGNET"), a New York-based healthcare private equity firm.
十月 23, 2022阅读更多
查看 Laxai 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。
